It has been reported that ERβ significantly affects ERα induced mRNA splicing in estrogen-responsive breast cancer cells (50), suggesting that ERβ has considerably different and, in most cases, opposite biological effects compared to ERα. Here, ESR2 is linked to breast carcinoma.